Abbott Norvir medical cost savings roughly offset cost of protease inhibitor -- MedTap study.
ABBOTT NORVIR MEDICAL COST OFFSETS ALMOST EQUAL ANNUAL DRUG PRICE in a cost analysis conducted by Arlington, Va.-based MedTap International and the University of North Carolina. The analysis presented at the July 11 International Conference on AIDS in Vancouver showed that adding Norvir (ritonavir) to standard antiviral therapy in advanced HIV led to a reduction of $6,382 in annual medical costs per patient. The wholesale acquisition cost of Norvir is about $6,500 per year.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth